Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Citius Pharmaceuticals Inc (CTXR)

Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 22,121
  • Shares Outstanding, K 7,229
  • Annual Sales, $ 0 K
  • Annual Income, $ -32,540 K
  • EBIT $ -41 M
  • EBITDA $ -41 M
  • 60-Month Beta 1.48
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.27

Options Overview Details

View History
  • Implied Volatility 183.22% ( +16.73%)
  • Historical Volatility 204.51%
  • IV Percentile 32%
  • IV Rank 13.39%
  • IV High 1,256.90% on 02/14/24
  • IV Low 17.20% on 10/10/24
  • Put/Call Vol Ratio 2.50
  • Today's Volume 7
  • Volume Avg (30-Day) 220
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 10,514
  • Open Int (30-Day) 11,504

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -2.00
  • Number of Estimates 1
  • High Estimate -2.00
  • Low Estimate -2.00
  • Prior Year -1.75
  • Growth Rate Est. (year over year) -14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.55 +12.16%
on 11/26/24
12.25 -76.65%
on 11/13/24
-9.20 (-76.28%)
since 11/12/24
3-Month
2.55 +12.16%
on 11/26/24
15.25 -81.25%
on 09/23/24
-10.08 (-77.89%)
since 09/12/24
52-Week
2.55 +12.16%
on 11/26/24
26.75 -89.31%
on 04/02/24
-17.01 (-85.61%)
since 12/12/23

Most Recent Stories

More News
Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 18, 2024) - Investorideas.com, a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks,...

CTXR : 2.86 (-6.54%)
Analysts Hunt for Undervalued Biotech Stocks

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 17, 2024) - Investorideas.com, a go-to investing platform releases the first of a two-part series looking at biotech/biopharma stocks,...

CTXR : 2.86 (-6.54%)
Bloodstream Infections - From Threats to Solutions

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com, a go-to investing platform releases the second of a two-part series looking at recent news and developments...

CTXR : 2.86 (-6.54%)
Biopharma Stocks Transformative Innovation for the Future of Health

Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com, a go-to investing platform releases the first of a two-part series looking at transformative innovation...

CTXR : 2.86 (-6.54%)
Goodbye ’23

Monday U.S. and Canada Christmas Day, Markets Closed Tuesday U.S. Economic ...

CVM : 0.7372 (+10.86%)
CTXR : 2.86 (-6.54%)
Citius Pharmaceuticals Reschedules Participation in Sidoti Small-Cap Virtual Investor Conference for November 2023

/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development...

CTXR : 2.86 (-6.54%)
Citius Pharmaceuticals Mourns the Loss of Board Member, Howard Safir

/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) mourns the loss of longtime board member, Howard Safir, who passed away...

CTXR : 2.86 (-6.54%)
Citius Pharmaceuticals, Inc. Receives Regulatory Guidance from the U.S. Food and Drug Administration (FDA) regarding the Planned Resubmission of the BLA for LYMPHIR™

/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) is pleased to announce the Company has received additional guidance...

CTXR : 2.86 (-6.54%)
Citius Pharmaceuticals to Participate in H.C. Wainwright and Sidoti Investor Conferences in September 2023

/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development...

CTXR : 2.86 (-6.54%)
Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2023 Financial Results and Provides Business Update

/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development...

CTXR : 2.86 (-6.54%)

Business Summary

Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in the development and commercialization of critical care products targeting medical needs with a focus on anti-infective products, adjunctive cancer care and prescription products. Citius Pharmaceuticals, Inc. is headquartered...

See More

Key Turning Points

3rd Resistance Point 3.39
2nd Resistance Point 3.24
1st Resistance Point 3.05
Last Price 2.86
1st Support Level 2.72
2nd Support Level 2.58
3rd Support Level 2.39

See More

52-Week High 26.75
Fibonacci 61.8% 17.51
Fibonacci 50% 14.65
Fibonacci 38.2% 11.79
Last Price 2.86
52-Week Low 2.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar